| Effect of hematocrit on solute removal during high efficiency hemodialysis. | |
| | |
MedLine Citation:
|
PMID: 2362408 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effect of changing hematocrit (Hct) on solute removal during high efficiency hemodialysis was evaluated in 12 patients. In five subjects, Hct was raised by recombinant human erythropoietin (rHuEPO) treatment, and in the other seven by blood transfusion. Solute removal was assessed by measuring: (1) whole blood (kb), blood water (kbw) and dialysate (kd) clearances; (2) the amount of solute in the spent dialysate; (3) the fractional decrement of serum solute concentration achieved by hemodialysis; and (4) urea kinetics, including kt/V and protein catabolic rate (PCR). The results showed that increasing the Hct did result in a slight reduction in some solute clearances. The decrement, however, was minor (5 to 8%), whereas the rise in Hct was marked (55 and 65%) in the transfused and EPO-treated groups, respectively. More importantly, linear regression analysis of kd/kb ratios versus Hct indicated that a rise of Hct from 20 to 40% would reduce creatinine and phosphate clearance by 8 and 13%, respectively. By contrast, assessment of the absolute amount of solute removed in the spent dialysate failed to detect differences between the two study periods. Additionally, a rise in Hct also did not affect urea kinetic parameters including kt/V and PCR. Based on these data, it appears prudent to increase hemodialysis prescription by 10 to 15% when Hct is raised to near 40% to avoid excessive retention of molecules with slow transcellular movement. |
| | |
Authors:
|
V S Lim; M J Flanigan; J Fangman |
Related Documents
:
|
3665448 - On the solution of equations for feel-better hemodialysis. 15384788 - Continuous-flow peritoneal dialysis: update. 20631678 - Real-time kt/v determination by ultraviolet absorbance in spent dialysate: technique va... 17729008 - Determination of the effect of a single hemodialysis session on retrobulbar blood hemod... 23469858 - Hsp27 protects the blood-brain barrier against ischemia-induced loss of integrity. 7839808 - Subclavian steal phenomenon. clinical and hemodynamic aspects. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Kidney international Volume: 37 ISSN: 0085-2538 ISO Abbreviation: Kidney Int. Publication Date: 1990 Jun |
Date Detail:
|
Created Date: 1990-08-06 Completed Date: 1990-08-06 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0323470 Medline TA: Kidney Int Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1557-62 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Blood Transfusion Erythropoietin / therapeutic use* Female Hematocrit* Humans Kidney Failure, Chronic / therapy* Male Recombinant Proteins / therapeutic use* Renal Dialysis / methods* |
| Grant Support | |
ID/Acronym/Agency:
|
RR55/RR/NCRR NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Recombinant Proteins; 11096-26-7/Erythropoietin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mononuclear cell activation and decreased renal function in IgA nephropathy with crescents.
Next Document: Isolation, culture and characterization of human peritoneal mesothelial cells.